CMCSA vs ESPR · P/E 8.6, rev $123.71B vs rev $332.3M
Comcast Corp (CMCSA) versus Esperion Therapeutics Inc (ESPR) — a side-by-side from cached financials, not a winner call.
Comcast Corp (CMCSA) is a telecom services company listed on US. It is led by Brian Roberts.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CMCSA revenue for 2025-12-31 was $123.71B. Net income was $20.00B. Revenue was down 0.0% from 2024-12-31 to 2025-12-31. CMCSA currently screens at market cap $130.64B and trailing P/E 8.6.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
CMCSA currently screens at market cap $130.64B and trailing P/E 8.6. ESPR currently screens at market cap $816.9M.
Not investment advice. Open the CMCSA and ESPR stock pages for the full models.
Not investment advice.